NYSE:SEMHealthcare
Will Select Medical Holdings' (SEM) Extended Buyback and Dividend Shift Its Capital Allocation Narrative?
Recently, Select Medical Holdings reaffirmed its 2025 revenue outlook, extended its US$1.0 billion stock repurchase program through the end of 2027, and declared a quarterly cash dividend.
This combination of operational confidence, shareholder capital returns, and steady expansion across 40 states highlights management’s commitment to growth and financial discipline.
We'll explore how the extended buyback program may support Select Medical Holdings' investment narrative and future capital...